United States v. Joel Smithers

92 F.4th 237
Court of Appeals for the Fourth Circuit·Decided February 2, 2024·No. 19-4761·Published·Cited by 5 cases

Opinion

PUBLISHED

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 19-4761

UNITED STATES OF AMERICA, Plaintiff - Appellee,

v.

JOEL A. SMITHERS, a/k/a Joel A Smithers, Defendant - Appellant.

Appeal from the United States District Court for the Western District of Virginia, at Abingdon. James P. Jones, Senior District Judge. (1:17-cr-00027-JPJ-PMS-1)

Submitted: October 27, 2023 Decided: February 2, 2024

Before GREGORY, RICHARDSON, and BENJAMIN, Circuit Judges.

Vacated and remanded by published opinion. Judge Gregory wrote the opinion, in which Judge Richardson and Judge Benjamin joined.

ARGUED: Beau B. Brindley, THE LAW OFFICES OF BEAU B. BRINDLEY, Chicago, Illinois, for Appellant. S. Cagle Juhan, OFFICE OF THE UNITED STATES ATTORNEY, Charlottesville, Virginia, for Appellee. ON BRIEF: Neal Lawrence Walters, SCOTT KRONER, PLC, Charlottesville, Virginia; Blair T. Westover, THE LAW OFFICES OF BEAU B. BRINDLEY, Chicago, Illinois, for Appellant. Daniel P. Bubar, Acting United States Attorney, OFFICE OF THE UNITED STATES ATTORNEY, Raleigh, North Carolina, for Appellee.

GREGORY, Circuit Judge:

Joel Smithers, until this prosecution a doctor of osteopathy, was convicted on 861 counts, all related to his opioid-prescription practices. He was sentenced to a total of 480 months in prison. After his conviction, the Supreme Court in Ruan v. United States, 597 U.S. 450 (2022), clarified the mens rea required to convict someone of unauthorized dispensing or distributing of a controlled substance. Because Ruan makes clear that Smithers’ jury instructions misstated the law, and because the misstatements were not harmless error, we vacate the convictions and remand to the district court for a new trial. We do not reach Smithers’ Confrontation Clause, sufficiency-of-the-evidence, or withdrawal-of-counsel challenges.

I.

On September 12, 2017, a grand jury indicted Joel Smithers on one count of possession of a controlled substance with intent to distribute, in violation of 21 U.S.C. §§ 841(a)(1) and (b)(1)(C). J.A. 101. Over the course of the next year, the government filed two superseding indictments. The first added 715 counts: one count of maintaining a place for the purpose of unlawful distribution, in violation of 21 U.S.C. § 856, and 714 counts of unlawful dispensing and distributing of a controlled substance. J.A. 102–03. The second superseding indictment added 146 counts of unlawful dispensing and distributing. J.A. 130– 31. The latter counts were charged under 21 U.S.C. § 841(a)(1), which (in addition to criminalizing possession with intent to dispense or distribute) provides that, “[e]xcept as authorized . . . , it [is] unlawful for any person knowingly or intentionally . . . to manufacture,

distribute, or dispense . . . a controlled substance.” The statute does not define “authorized.” Instead, Drug Enforcement Agency regulations define it: a prescription is only authorized when “issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.” 21 C.F.R. § 1306.04.

Because of the government’s superseding indictments, the district court granted Defendant’s two motions to continue the trial and moved the trial to April 29, 2019. J.A. 157A. On March 18, 2019, defense counsel moved for a third continuance. J.A. 158. He said the government had provided him with multiple CDs, containing over 4,000 pages of discovery, just three days before, and that he did not have time to review the evidence before trial. J.A. 158. On March 22, the magistrate judge held a hearing on the motion. J.A. 161–92. The government said that a former AUSA had received the documents in December 2018, but had retired soon after, and the documents likely “got lost in the shuffle.” J.A. 171. According to the government, roughly half of the documents in the CDs had been produced to the defendant earlier in the case. J.A. 193. The magistrate judge denied Smithers’ motion to continue but ruled that the government would not be allowed to use at trial any document or information it provided to defense counsel for the first time on March 15, 2019. J.A. 194.

After one more motion to continue, one motion by defense counsel to withdraw, and one motion for reconsideration of the denial of the motion to withdraw, J.A. 203, 212–13, 214, 215W, 215Z, 215AA—all of them unsuccessful and none of them material to the disposition of this case—the trial began on April 29, 2019. J.A. 216–17.

II.

A.

The government presented eighteen witnesses at trial. Two were expert witnesses, eight were patients, and eight were miscellaneous lay witnesses (former employees, law enforcement, state licensing agents, etc.). The witnesses testified to the following facts. Many patients didn’t pay for their own prescriptions, appointments, or travel to Smithers’ office. J.A. 250–51, 293–94, 359–60, 389. Someone else did (usually a person named Darryl Williams or a person named Rick Jessie), and in exchange, the patients gave half or more of their pills to that person. J.A. 250–51, 359, 389. A number of Smithers’ patients failed drug tests—they either tested positive for drugs they had not been prescribed or tested negative for drugs they had been prescribed, an indication that they were diverting those drugs for other purposes. J.A. 259, 450, 875, 879, 881–82, 883. Another patient failed a pill count, showing up with fewer pills than she should have had, given how frequently she was supposed to take them. J.A. 458. Despite those failed tests, Smithers continued to see them and continued to prescribe drugs to them. J.A. 262, 452–54. One of the patient witnesses had a prior conviction for selling prescription pills, but Smithers never drug tested her. J.A. 361. Another patient had been charged with drug trafficking and withholding information to obtain a controlled substance. J.A. 406. Smithers signed a form indicating he was aware of those charges yet continued prescribing to her. J.A. 406–07. Smithers also knew that another patient had been on Suboxone, a drug-addiction medication, in the past, but continued prescribing to her. J.A. 458.

All of the patients who testified had to drive many hours to reach the office. See, e.g., J.A.

253 (six- to ten-hour round trip), 291–92 (eight- to ten-hour round trip). For one patient, it was a twelve- to thirteen-hour round trip. J.A. 327. After making it to the office, they often had to drive another hour or more to one of the few pharmacies that would fill their prescriptions. One patient had to go to a pharmacy five to six hours away from her home. J.A. 409.

Occasionally, Smithers sent patients prescriptions via mail without requiring them to come into the office. J.A. 256, 300, 399. But they still had to pay the full $300 office-visit fee. J.A. 399. When patients did come into the office, they would sometimes wait for eight to twelve hours. J.A. 541. Sometimes, Smithers wasn’t even there. J.A. 324. According to an office employee, in a typical four-day week (the office was open only four days), Smithers was there only one or two days. J.A. 547. Patients would meet with him via Facetime from the office, id., and they’d be given prescriptions from a pre-signed prescription pad. J.A. 532–33.

Smithers wrote prescriptions for one person, the ex-wife of Darryl Williams (one of the men who paid for patients’ visits in exchange for pills), without ever seeing her. J.A. 342–47. Though the prescriptions were written in that woman’s name, she never received them, J.A. 344, 347; they were instead sent to Williams’ house.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Joel Smithers, 92 F.4th 237 (4th Cir. 2024).

92 F.4th 237 (United States v. Joel Smithers) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Kirsten Ball
Fourth Circuit, 2026
United States v. Otuonye
Tenth Circuit, 2026
United States v. Marilyn Mosby
143 F.4th 264 (Fourth Circuit, 2025)
United States v. Sanjay Kumar
Fourth Circuit, 2024